Clinical Trial Update: Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge [Phase 2]

View source ↗

Summary

Phase 2 trial update reports on early effects of a new oral nicotine replacement product used in combination with NiQuitin Lozenge for smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• New Oral Nicotine Replacement Product (nicotine replacement product (oral))
• NiQuitin Lozenge (nicotine lozenge)

Snippet

Sponsor: McNeil AB | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED